Anti-Cytochrome P450 1A2 antibody [d15 (16VII F10F12)]
4
(6 Reviews)
|
(31 Publications)
Mouse Monoclonal Cytochrome P450 1A2 antibody. Suitable for IHC-P, Flow Cyt, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 31 publications. Immunogen corresponding to Full Length Protein corresponding to Rat Cyp1a2.
View Alternative Names
Cyp1a-2, Cyp1a2, Cytochrome P450 1A2, CYPIA2, Cholesterol 25-hydroxylase, Cytochrome P-448, Cytochrome P-450d, Cytochrome P450-D, Hydroperoxy icosatetraenoate dehydratase
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 1A2 antibody [d15 (16VII F10F12)] (AB22717)
ab22717 staining human normal liver. Staining is localised to the cytoplasm.
Left panel : with primary antibody at 1 ug/ml. Right panel : isotype control.
Sections were stained using an automated system DAKO Autostainer Plus , at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 antigen retrieval buffer citrate pH 6.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cytochrome P450 1A2 antibody [d15 (16VII F10F12)] (AB22717)
ICC/IF image of ab22717 stained MCF7 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab22717, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- Flow Cyt
Unknown
Flow Cytometry - Anti-Cytochrome P450 1A2 antibody [d15 (16VII F10F12)] (AB22717)
Overlay histogram showing MCF7 cells stained with ab22717 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab22717, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- WB
AbReview25313****
Western blot - Anti-Cytochrome P450 1A2 antibody [d15 (16VII F10F12)] (AB22717)
All lanes:
Western blot - Anti-Cytochrome P450 1A2 antibody [d15 (16VII F10F12)] (ab22717) at 1/2500 dilution
All lanes:
Tissue lysate prepared from murine liver microsomes at 10 µg
Secondary
All lanes:
Goat anti-mouse IgG(H+L)-HRP conjugate at 1/5000 dilution
Predicted band size: 58 kDa
true
Exposure time: 1s
Image courtesy of an anonymous Abreview.
- WB
Unknown
Western blot - Anti-Cytochrome P450 1A2 antibody [d15 (16VII F10F12)] (AB22717)
All lanes:
Western blot - Anti-Cytochrome P450 1A2 antibody [d15 (16VII F10F12)] (ab22717) at 1 µg/mL
Lane 1:
Human liver tissue lysate - total protein (<a href='/en-us/products/unavailable/human-liver-tissue-lysate-total-protein-ab29889'>ab29889</a>) at 10 µg
Lane 2:
Liver (Mouse) Tissue Lysate at 10 µg
Lane 3:
Liver (Rat) Tissue Lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/5000 dilution
Predicted band size: 58 kDa
Observed band size: 30 kDa,48 kDa,58 kDa
true
Exposure time: 150s
Reactivity data
Product details
Isotype
IgG1/IgG2a kappa
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CYP1A2 plays a central role in the oxidative biotransformation of drugs and procarcinogens. It does not form part of a larger complex but interacts dynamically with other enzymes in the detoxification process. CYP1A2 metabolizes several clinical drugs such as caffeine and theophylline and regulates the detoxification of aromatic amines and hydrocarbons. Studying CYP1A2 inhibitors can provide insights into clinically relevant drug interactions and potential side effects in pharmacotherapy.
Pathways
CYP1A2 functions within the drug metabolism and synthesis of cholesterol steroids and other lipids pathways. In the drug metabolism pathway CYP1A2 works alongside other cytochrome P450 enzymes such as CYP1A1 and CYP1B1 which together ensure the metabolism and clearance of various exogenous and endogenous compounds. These pathways are vital for maintaining drug efficacy and preventing toxicity through the metabolic clearance of pharmaceutical agents and harmful substances.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (31)
Recent publications for all applications. Explore the full list and refine your search
British journal of pharmacology 180:2973-2988 PubMed37403641
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 14:1151340 PubMed37035728
2023
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 13:648-661 PubMed36873188
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:21825 PubMed36528753
2022
Applications
Unspecified application
Species
Unspecified reactive species
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 181:106358 PubMed36513193
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:7345 PubMed36446858
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2022:2481654 PubMed36285162
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:977370 PubMed36188572
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:3317 PubMed35680907
2022
Applications
Unspecified application
Species
Unspecified reactive species
EBioMedicine 66:103307 PubMed33819741
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com